Lithium in Severe Depression
نویسندگان
چکیده
منابع مشابه
Endorphin Agonists for Severe Depression
Endorphins and endorphin agonists play a crucial role in the neural modulation of mood, anxiety, pain and addiction. Recent studies have elucidated the crucial mechanism of enhancing prefrontal cortex influence and dampening limbic and sub cortical influences in depression and remission consistent with the biological profile of endorphin agonists. The historical, biological, experimental and cl...
متن کاملLithium decreases plasma adiponectin levels in bipolar depression.
Lithium, a first line treatment for bipolar disorder (BD), has been associated with significant weight gain, but the mechanisms underlying this phenomenon are still unclear. It has been suggested that changes in production/release of adipokines - molecules secreted by adipose tissue presenting anti-inflammatory (adiponectin) and pro-inflammatory (leptin, resistin) properties - might be implicat...
متن کاملComparison of Anxiety and Quality of Life in Patients with Severe and Mild Depression
Background and Aims: This study aimed to compare levels of anxiety and quality of life in patients with severe and mild depression. Material and Methods: In a causal-comparative design, 271 patients with Major Depressive Disorder were selected using convenience sampling method and based on the Structured Clinical Interview and then, they were asked to complete New Multidimensional Depression As...
متن کاملBenefits of omalizumab on anxiety and depression in patients with severe asthma
Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Inventory (STAI). Methods: Anxiety level was determined with STAI, whereas depression level was ...
متن کاملTreatment of unipolar psychotic depression: an open study of lithium addition in refractory psychotic depression.
Objective: This study was designed to compare the efficacy of three two-phase pharmacological treatment strategies for inpatients with DSM-IV-TR major depressive disorder with psychotic features. Method: During phase I, 122 patients participated in a 7 week double-blind eight center study comparing imipramine (dose adjusted to target plasma levels of 200300 ng/ml), venlafaxine (maximum 375 mg/d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Psychiatry
سال: 1985
ISSN: 0007-1250,1472-1465
DOI: 10.1192/s0007125000207502